Latest filing published 16 Jan 2026 for InspireMD, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -74.5%Entry US$2.67 · Close at T+365 US$0.68
- -86.4%Entry US$19.65 · Close at T+365 US$2.68
- -43.4%Entry US$10.35 · Close at T+365 US$5.86
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Marvin Slosman: trading record in brief
This profile gathers the share dealings of Marvin Slosman in InspireMD, Inc., where the filings describe the role as chief executive. Over a trading history stretching from 2 January 2020 to 14 January 2026, the count stands at 10 filings.
No open-market sale appears; the market trades are 3 purchases worth €65k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 7 share grants.
In size, the median ticket on the buying side is €22k. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Ninety days after publication, 3 purchases show a median change of -46.4%, with the price up in 0% of them. Past outcomes like these are no guarantee of what comes next.
The newest entry dates from 16 January 2026: a share grant, in InspireMD, Inc. The latest purchase dates back some time: it was published 466 days ago, on 1 August 2025. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Marvin Slosman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,114,792 shares0Restricted Stock UnitsSEC:0001493152-26-002668:0
- 10,330 shares@ US$2.42100.0% of flowCommon StockSEC:0001641172-25-021931:0Canonical exit: 28 Oct 2025 (T+90)
- 558,417 shares0Restricted Stock UnitsSEC:0001493152-25-001731:0
- 563,499 shares0Restricted Stock UnitsSEC:0001493152-24-003773:0
- 1,045,150 shares0Restricted Stock UnitsSEC:0001493152-23-018327:0
- 146,567 shares0Restricted Stock UnitsSEC:0001493152-21-025454:0
- 40,320 shares@ US$0.6232.1% of flowCommon StockSEC:0001493152-21-003209:0Canonical exit: 9 May 2021 (T+90)
- 1,175,287 shares0Common StockSEC:0001493152-20-017128:0
- 55,550 shares@ US$0.4550.2% of flowCommon StockSEC:0001493152-20-010852:0Canonical exit: 3 Sept 2020 (T+90)
- 182,381 shares0Common StockSEC:0001493152-20-000103:0
10 of 10 declarations
